Gene expression profiling of midbrain dopamine neurons upon gestational nicotine exposure

2016 ◽  
Vol 55 (3) ◽  
pp. 467-482 ◽  
Author(s):  
Pınar Kanlikilicer ◽  
Die Zhang ◽  
Andrei Dragomir ◽  
Yasemin M. Akay ◽  
Metin Akay

2020 ◽  
Vol 43 (3) ◽  
pp. 155-169 ◽  
Author(s):  
Jean-Francois Poulin ◽  
Zachary Gaertner ◽  
Oscar Andrés Moreno-Ramos ◽  
Rajeshwar Awatramani




2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Amanda L. Brown ◽  
Trevor A. Day ◽  
Christopher V. Dayas ◽  
Doug W. Smith

The ability to microdissect individual cells from the nervous system has enormous potential, as it can allow for the study of gene expression in phenotypically identified cells. However, if the resultant gene expression profiles are to be accurately ascribed, it is necessary to determine the extent of contamination by nontarget cells in the microdissected sample. Here, we show that midbrain dopamine neurons can be laser-microdissected to a high degree of enrichment and purity. The average enrichment for tyrosine hydroxylase (TH) gene expression in the microdissected sample relative to midbrain sections was approximately 200-fold. For the dopamine transporter (DAT) and the vesicular monoamine transporter type 2 (Vmat2), average enrichments were approximately 100- and 60-fold, respectively. Glutamic acid decarboxylase (Gad65) expression, a marker for GABAergic neurons, was several hundredfold lower than dopamine neuron-specific genes. Glial cell and glutamatergic neuron gene expression were not detected in microdissected samples. Additionally, SN and VTA dopamine neurons had significantly different expression levels of dopamine neuron-specific genes, which likely reflects functional differences between the two cell groups. This study demonstrates that it is possible to laser-microdissect dopamine neurons to a high degree of cell purity. Therefore gene expression profiles can be precisely attributed to the targeted microdissected cells.



1990 ◽  
Vol 80 (3) ◽  
Author(s):  
N. Lindefors ◽  
S. Bren� ◽  
M. Herrera-Marschitz ◽  
H. Persson


Brain ◽  
2008 ◽  
Vol 132 (7) ◽  
pp. 1795-1809 ◽  
Author(s):  
Filip Simunovic ◽  
Ming Yi ◽  
Yulei Wang ◽  
Laurel Macey ◽  
Lauren T. Brown ◽  
...  


2011 ◽  
Vol 204 (1) ◽  
pp. S101
Author(s):  
Hee young Cho ◽  
Hyewon Hur ◽  
Ga Hyun Son ◽  
Ha Yan Kwon ◽  
Yong Won Park ◽  
...  


2002 ◽  
Vol 69 ◽  
pp. 135-142 ◽  
Author(s):  
Elena M. Comelli ◽  
Margarida Amado ◽  
Steven R. Head ◽  
James C. Paulson

The development of microarray technology offers the unprecedented possibility of studying the expression of thousands of genes in one experiment. Its exploitation in the glycobiology field will eventually allow the parallel investigation of the expression of many glycosyltransferases, which will ultimately lead to an understanding of the regulation of glycoconjugate synthesis. While numerous gene arrays are available on the market, e.g. the Affymetrix GeneChip® arrays, glycosyltransferases are not adequately represented, which makes comprehensive surveys of their gene expression difficult. This chapter describes the main issues related to the establishment of a custom glycogenes array.



2007 ◽  
Vol 177 (4S) ◽  
pp. 93-93
Author(s):  
Toshiyuki Tsunoda ◽  
Junichi Inocuchi ◽  
Darren Tyson ◽  
Seiji Naito ◽  
David K. Ornstein


Sign in / Sign up

Export Citation Format

Share Document